To treat adults with mild to severe plaque psoriasis, TREMFYA® is prescribed as an injection or pill or phototherapy (systemic therapy) (treatment UV or Ultraviolet light).
Individuals with the active psoriatic arthritis are prescribed TREMFYA®.
A person’s health insurance and support options will have a significant impact on how much they pay for prescription medications.
Your out-of-pocket prices can vary depending on the dosage, the type of treatment you receive, and the location of your treatment. Contact the insurance provider to learn more about your specific plan.
Dosing and indications can affect the price listed on the product page. Induction dosages, the cost of administering a dose, and pharmacy fees are not included in the list price.
In the United States, 75% of patients pay nothing or as little as $15 a month. After applying insurance benefits, out-of-pocket costing are derived from approved pharmacy claims and normalized to a 30-day supply.
Health claims, induction dosage, or the cost of administering a dose are not included in the cost of the medication. This is based on IQVIATM: IQVIATM out of Pocket Expense (OPC) Tool forecasts of real-world activity for the period January 2019 – Dec. 2019.
Tremfya saving program
Patients with private or commercial insurance who are eligible for TREMFYA® can reduce their out-of-pocket expenses. Each injection costs $5 for those who qualify.
The program’s annual benefit limit will be enforced. If you’re using a government-funded program to pay for your medication, this discount is not valid.
The terms of this agreement are subject to renewal at the ending of the current calendar year. There is also no income limit for participation. The cost of administering your injection is not covered by the program. Check out the full list of requirements here.
